P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC

Horne, A., Brown, S., Coyle, V. et al. (13 more authors) (2023) P2.01-04 An Update on the CONCORDE study: A Phase Ib Platform Study of Novel Agents in Combination With Conventional Radiotherapy in NSCLC. In: Journal of Thoracic Oncology. 2023 World Conference on Lung Cancer, 09-12 Sep 2023, Singapore. Elsevier BV , S296-S297.

Metadata

Item Type: Proceedings Paper
Authors/Creators:
  • Horne, A.
  • Brown, S.
  • Coyle, V.
  • Franks, K.
  • Hassani, A.
  • Harrow, S.
  • Hatton, M. ORCID logo https://orcid.org/0000-0003-2778-7926
  • Hiley, C.
  • Kendall, J.
  • Oughton, J.B.
  • Shaw, P.
  • Walker, F.
  • Yang, H.
  • Chalmers, A.J.
  • Faivre-Finn, C.
  • Greystoke, A.
Copyright, Publisher and Additional Information:

© 2023 Published by Elsevier Inc.
Keywords: Radiotherapy trial; Early phase study; DNA damage response inhibitors
Dates:
  • Published (online): 31 October 2023
  • Published: November 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 29 Aug 2024 14:35
Last Modified: 29 Aug 2024 14:43
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.jtho.2023.09.509
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)